The DOI matches its Crossref record.
Applications of Magnetic Nanoparticles in Targeted Drug Delivery System
Abstract
Magnetic nanoparticles (MNPs) are a special kind of nanomaterials and widely used in biomedical technology applications. Currently they are popularly customized for disease detection and treatment, particularly as drug carriers in drug targeted delivery systems, as a therapeutic in hyperthermia (treating tumors with heat), and as contrast agents in magnetic resonance imaging (MRI). Due to their biocompatibility and superparamagnetic properties, MNPs as next generation drug carriers have great attraction. Although the potential benefits of MNPs are considerable, any potential toxicity associated with these MNPs should be identified distinctly. The drug loading capability and the biomedical properties of MNPs generated by different surface coatings are the most sensitive parameters in toxicity. A lot of organic and inorganic materials are utilized as coating materials for surface functionalization and reducing toxicity of MNPs. pH or temperature sensitivity materials are widely used to manage drug loading and targeted release. In addition, MNPs can be controlled and directed to the desired pathological region by using external magnetic files (EMF). The realization of targeted drug delivery has decreased the dosage and improved the efficiency of drugs, which results in reduced side effects to normal tissues. This review discussed the possible organ toxicities of MNPs and their current advances as a drug delivery vehicle.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Advances in Magnetic Nanoparticles for Biomedical Applications
Cardoso, V. F., Francesko, A., Ribeiro, C., Bañobre‐López, M., Martins, P., & Lanceros‐Mendez, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700845 · Cited by 723
Wu, W., Jiang, C. Z., & Roy, V. A. L. (2016) · Nanoscale · doi:10.1039/c6nr07542h · Cited by 417
Biomedical Applications of Iron Oxide Nanoparticles: Current Insights Progress and Perspectives
Montiel Schneider, M. G., Martín, M. J., Otarola, J., Vakarelska, E., Simeonov, V., Lassalle, V., & Nedyalkova, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010204 · Cited by 302
Recent advances in nano scaffolds for bone repair
Yi, H., Ur Rehman, F., Zhao, C., Liu, B., & He, N. (2016) · Bone Research · doi:10.1038/boneres.2016.50 · Cited by 266
Self-citationThe use of magnetic nanoparticles in cancer theranostics: Toward handheld diagnostic devices
Hajba, L., & Guttman, A. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.02.001 · Cited by 111
Organ-specific toxicity of magnetic iron oxide-based nanoparticles
Chrishtop, V. V., Mironov, V. A., Prilepskii, A. Y., Nikonorova, V. G., & Vinogradov, V. V. (2021) · Nanotoxicology · doi:10.1080/17435390.2020.1842934 · Cited by 86
Small versus Large Iron Oxide Magnetic Nanoparticles: Hyperthermia and Cell Uptake Properties
Iacovita, C., Florea, A., Dudric, R., Pall, E., Moldovan, A., Tetean, R., Stiufiuc, R., & Lucaciu, C. (2016) · Molecules · doi:10.3390/molecules21101357 · Cited by 57
PH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles
García Rubia, G., Peigneux, A., Jabalera, Y., Puerma, J., Oltolina, F., Elert, K., Colangelo, D., Gómez Morales, J., Prat, M., & Jimenez-Lopez, C. (2018) · Langmuir · doi:10.1021/acs.langmuir.8b03109 · Cited by 53
Surface functionalized magnetic nanoparticles for targeted cancer therapy and diagnosis
Saifullah, S., Ali, I., Kawish, M., El-Shabasy, R. M., Chen, L., & El-Seedi, H. R. (2020) · Metal Nanoparticles for Drug Delivery and Diagnostic Applications · doi:10.1016/b978-0-12-816960-5.00012-4 · Cited by 13
Pratt, J., Haidara, K., & Annabi, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214214 · Cited by 8
Metadata
- Authors
- Mou, X., Ali, Z., Li, S., & He, N.
- Venue
- Journal of Nanoscience and Nanotechnology
- Publisher
- American Scientific Publishers
- Published
- 2015-01-01
- Volume
- 15
- Issue
- 1
- Pages
- 54-62
- ISSN
- 1533-4880 (ISSN-L)
- 1533-4899
- OpenAlex
- W2326355689
- Cited by
- 235
- References
- 0
- FWCI
- 7.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.